World Sleep Industry ENCYCLOPEDIA

Circadian Light Therapy Lamps

1.3.1

Definition, product forms, and category boundaries

A circadian light therapy lamp is a device whose main output is eye-mediated visible-light exposure, specified by spectrum, illuminance at the eye, exposure geometry, and timing to provide a time cue to the circadian system. In this encyclopedia it belongs to WSIC 1.3.1, light-regulation equipment. It may be sold as a consumer aid for daily schedules, or it may enter a medical-product framework when intended to treat seasonal depression or a circadian sleep-wake disorder. The term “light therapy” alone establishes neither indication, efficacy, nor regulatory status.

Common forms include desktop light boxes, large diffusing panels on stands, angle-adjustable floor lamps, and connected luminaires that change output on a schedule. Some deliver higher illuminance at the eye for a shorter period, while others extend exposure at a lower level. Emitting area, diffuser, distance, and fraction of the visual field all change the experience. Dawn simulators, ordinary task lamps, decorative mood lights, integrated architectural lighting, ultraviolet equipment for skin treatment, and light sources worn immediately in front of the eyes are not equivalent merely because they all emit light.

Circadian action arises from retinal pathways after light enters the eye, not from illumination of the skin, a bright-looking room, or high electrical wattage. The intended purpose, target population, proposed time of use, and actual output conditions should be explicit. If a general lamp uses terms such as daylight simulation, full spectrum, or energy light but provides no measurements at a stated distance, direction, and spectrum, those labels do not show that it can deliver a reproducible circadian stimulus.

Eye-level dose, spectrum, and measurement language

Illuminance at the location and orientation of the eyes is closer to actual exposure than faceplate brightness, luminous flux, or electrical power. However, illuminance in lux is weighted for photopic vision and does not completely describe non-visual circadian effects. Relevant specifications also include spectral power distribution, measurement distance, direction of incidence, effective emitting area, uniformity, and stabilization time. Correlated colour temperature, colour rendering, and a daylight-white description are lighting characteristics, not substitutes for circadian dose.

CIE S 026 establishes metrology for stimulation of five retinal photoreceptor classes. Quantities such as melanopic equivalent daylight illuminance can describe melanopsin-related spectral stimulation more clearly than lux alone. The system is nevertheless a measurement language; it does not independently predict an individual's phase shift, alerting response, or treatment outcome, and it does not address flicker, glare, or photobiological safety. Reducing every physiological result to one “circadian index,” or treating a peak wavelength as the only active component, removes essential context.

Retinal exposure is further modified by pupil size, age-related lens transmission, field of view, gaze direction, spectacles or contact lenses, prior light history, and concurrent ambient light. The same lamp can deliver very different eye-level doses when close and frontal, distant and lateral, or blocked by a display. A claim of 10,000 lux must identify the distance and usable area where it is achieved. A user should not move closer, remove a diffuser, or stare continuously at the source merely to pursue the label value.

Timing, phase response, and an individualized plan

The circadian effect of light depends strongly on timing. For a conventional daytime schedule, bright light in the early biological night generally shifts rhythms later, whereas light in the late biological night or morning generally shifts them earlier; direction and magnitude still depend on individual phase. “Morning use” or “evening use” therefore cannot be applied without regard to the goal, sleep schedule, and physiological phase. The same lamp at the wrong time may move sleep onset and wake time farther from the target.

Clock time is not itself biological phase. A sleep diary, continuous schedule records, optional actigraphy, and—under specialist conditions—markers such as dim-light melatonin onset can help distinguish an advanced rhythm, delayed rhythm, shift-work misalignment, and another cause of insomnia. A plan should also address wake time, daytime outdoor light, evening dimming, and the screen environment. Adding one bright exposure without recording light and darkness across the day makes a null or reversed response difficult to interpret.

Intensity and duration jointly influence exposure, but a simple lux-minute product does not make different spectra, field sizes, or circadian times fully interchangeable, and visual adaptation and physiological response are not indefinitely linear. Duration, distance, and titration should follow a protocol validated for the model or professional guidance. Missed exposure should not be compensated for by making the light brighter, bluer, closer, or longer. When time zones, work shifts, or seasons change, an old schedule may no longer fit and must not extend bright light into the new intended sleep period.

Optical, electrical, and human-factors safety

Photobiological safety should be assessed at the intended distance, reasonably foreseeable close distances, and the longest allowed exposure. The assessment considers ultraviolet, retinal blue-light, and thermally related hazards using radiance or irradiance conditions appropriate to an extended source. “UV-free” answers only part of the spectral question and does not establish evaluation of blue light, near-infrared radiation, or high luminance. A standards claim should apply to the complete lamp, accessories, viewing distance, and risk group, not merely to data for one LED package.

A large, uniform diffuser can reduce glaring hotspots, but reflected images, bright edges, temporal light modulation during dimming, and driver noise still require attention. Absence of camera banding, visible flicker, or instability in a phone illuminance app does not replace suitable instrumentation. Placement should allow light into the field of view without requiring a fixed stare, avoid strong reflections in mirrors, glass, or glossy displays, and not use sunglasses as a workaround for excessive output.

The stand should remain stable at specified angles and not tip during a light touch, cable pull, or panel adjustment. Hinges, ventilation openings, adapters, and power cords must not be covered by bedding. Abnormal case temperature, scorching odor, uncontrolled flicker, sudden brightness changes, a cracked diffuser, or intermittent power calls for withdrawal from use. Following power loss, firmware update, time-zone change, or daylight-saving transition, the device should not resume a high-output session unnoticed, and a clear local stop and manual control should remain available.

Use workflow, performance verification, and record meaning

Initial setup should establish the seat, emitting height, distance, and lateral angle from the model's instructions, allowing normal visual activity during the planned session rather than requiring a stare at the luminous surface. Recent sleep, wake time, medication, and the principal symptom should be recorded, while eye discomfort, headache, nausea, agitation, and changes in sleepiness are monitored. High-output light should not be casually tested around driving or tasks requiring dark adaptation, and a roommate should not be made to receive another person's prescribed schedule passively.

Finished-product verification should measure illuminance and spectral distribution across the specified eye plane, including centre and edges, permitted distances and angles, cold start to stability, output levels, dimming, aging, and supply variation; applicable alpha-opic quantities can then be calculated. Temporal modulation, glare, ultraviolet leakage, timer accuracy, schedules crossing midnight, power recovery, tip-over, and surface temperature also require verification. A measurement at the centre of the lamp face or a component-level LED specification does not represent whole-device output at the user's eyes.

An app log stating “session completed” usually means only that the lamp switched on or its countdown ended. It does not show that the user remained at the specified location, kept the eyes open, or received the target eye-level dose. When a presence detector, camera, or ambient-light sensor is used, the product should explain whether it measures occupancy, posture, room illuminance, or actual ocular exposure and how obstruction and multiple people are handled. Logs can support adherence interpretation but cannot diagnose a circadian disorder or prove that phase shifted.

Clinical evidence, suitable users, and care boundaries

Bright-light therapy has clinical use and research support for seasonal affective disorder, but studies differ in white-light output, intensity, timing, treatment course, and comparator. Their aggregate result does not establish that any online lamp is effective. A specific advantage of blue-only light remains unproven, so “more blue means stronger treatment” is not a valid selection rule. Low mood may instead reflect nonseasonal depression, bipolar disorder, or another condition, and a lamp cannot replace diagnosis, psychotherapy, medication management, or crisis care.

For some circadian rhythm sleep-wake disorders, professional guidance supports strategically timed light in selected patients, sometimes together with behavioural scheduling. Insomnia studies suggest improvement in some outcomes, but protocols are heterogeneous and benefits do not cover every sleep measure; bright light is not a universal intervention for all chronic insomnia. Morning alertness, subjective energy, or acute melatonin suppression does not show that the cause of insomnia has been treated, nor does a short-term response establish long-term health benefit.

A person with bipolar disorder or a history of mania or hypomania requires clinical monitoring. A new marked reduction in need for sleep, unusual energy, racing thoughts, irritability, impulsivity, or risk-taking warrants stopping self-adjustment and promptly contacting a clinician. Pre-existing eye disease, recent ophthalmic treatment, or medication that increases photosensitivity also calls for an appropriateness check. Persistent depression, major functional loss, or thoughts of self-harm or suicide requires timely medical or emergency help, not a longer light session.

Cleaning, data governance, and claim limits

The lamp should be unplugged and allowed to cool before the diffuser and housing are cleaned as instructed, keeping liquid out of ventilation slots, hinges, and power connectors. Abrasives, solvents, films, coloured filters, a discoloured diffuser, and dust can alter transmission and spectrum and should not be compensated for with a higher setting. The stand, cable, adapter, timer, and apparent output require periodic inspection. After the rated service life or replacement of a light source during repair, the original dose information may no longer apply.

A connected model may store sleep schedules, mood, medication, time zone, light exposure, and occupancy information from which routines and health state can be inferred. It should disclose local and cloud processing, retention, account access, export and deletion, firmware support, and offline control during a service outage. Automatic scheduling should show its basis and the next high-output interval and permit immediate cancellation. An algorithm update must not change clinically relevant exposure timing or dose without notice.

The appropriate unit for evaluating a circadian light therapy lamp is a combination of specified timing, eye-level spectrum and illuminance, duration, and population. Full spectrum, simulated sunlight, high colour rendering, flicker-free, or a melanopic value alone cannot support promises to reset the body clock, cure insomnia or depression, boost immunity, or guarantee deep sleep. An efficacy conclusion must correspond to the studied model or equivalent output, geometry, schedule, co-interventions, and clinical outcome; compliance with a safety standard is not efficacy evidence.